|
|
MICB606 4
CREDITS Fall 2008
Public Policy for Scientists
Tu-Th 3:00 - 4:30
pm - NE 301 Med/Dent
SEE Dr. Calderone (NW302
Med/Dent)
|
DATE |
TOPIC |
SPEAKER |
LOCATION |
|
Aug 28 |
Introduction , academia and the biomedical
scientist; peer review |
Richard Calderone,
PhD |
GU |
|
Sept 2 |
Peer review 2 |
Richard Calderone |
|
|
Sept 4 |
NIH and programs |
Susan Daniels, PhD |
NIH-NIAID |
|
Sept 9 |
Science policy & current issues |
Susan Daniels |
|
|
Sept 11 |
US Domestic Science Policy: |
Dennis Mc Bride, PhD |
Potomac Institute for Policy |
|
Sept 16 |
US Domestic Science Policy: |
Dennis McBride |
|
|
Sept 18 |
Providing Scientific Advice |
James Tate |
Potomac Institute |
|
Sept 23 |
Federal R&D Budget |
Kei Koizumi, M.A. |
AAAS |
|
Sept 25 |
Federal R & D |
Kei Koizumi |
|
|
Sept 30 |
Federal R&D Budget |
Kei Koizumi |
|
|
Oct 2 |
Global Science Policy |
David Siegrist, PhD |
Potomac Institute for Policy |
|
Oct 7 |
Global Health Policy |
David Siegrist |
|
|
Oct 9 |
Global Health Policy |
David Siegrist |
|
|
Oct 14 |
Global Health Policy |
David Siegrist |
|
|
Oct 16 |
Discussion
of topics for oral presentations |
Calderone/McBride |
|
|
Oct 21 |
Mid -Term Exam |
|
|
|
Oct 23 |
Science lobbying & Advocacy |
Benn Tannenbaum, PhD |
AAAS |
|
Oct 28 |
Science lobbying & Advocacy |
Benn Tannenbaum, |
|
|
Oct 30 |
Science lobbying & Advocacy |
Benn Tannenbaum, |
|
|
Nov 4 |
Science lobbying & Advocacy |
Benn Tannenbaum, |
|
|
Nov 6 |
Health, Science, and Economics |
Douglas Brown, PhD |
GU, Dept of Economics |
|
Nov 11 |
Health, Science, and Economics |
Douglas Brown |
|
|
Nov 13 |
Health, Science, and Economics |
Douglas Brown |
|
|
Nov 18 |
Health, Science, and Economics |
Douglas Brown |
|
|
Nov 20 |
Biomedical Ethics |
Kevin Fitzgerald, SJ, PhD |
Kennedy Institute for Bioethics, GU |
|
Nov 25 |
Biomedical Ethics |
Kevin Fitzgerald |
|
|
Dec 2 |
Oral presentations |
McBride/Calderone |
|
|
Dec 10-18 |
Final Exam - TBA |
|
|
This interdisciplinary course will
provide introductory lectures in a variety of fields that pertain to
biomedical science policy & advocacy. Lectures will cover relevant
federal agencies, prominent science advocacy groups and techniques,
principles of health economics, funding of research activities, the
interaction of science & industry, as well as some controversial issues
in science policy such as biodefense, stem cell research, and climate
change. Students will be left with a multi-faceted understanding of the
environment that shapes biomedical science policy and the scientists’
role in this arena
|
